Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Anticoagulants are medicinal substances that reduce blood clotting and prolong clotting time. Anticoagulant drugs achieve their effects by inhibiting the synthesis or function of various coagulation factors in the blood.
North America is expected to remain dominant throughout the forecast period. The global anticoagulants market is expected to grow at a compound annual growth rate (CAGR) of 5.6% during the forecast period from 2020 to 2026.
The global anticoagulant market is expected to grow due to the introduction of drugs with lower side effects and higher efficacy, the increasing prevalence of cardiovascular disease worldwide and the increased adoption of new oral anticoagulants (NOACs) in North America and Europe.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Anticoagulants market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Anticoagulants market. Detailed analysis of key players, along with key growth strategies adopted by Anticoagulants industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Sanofi
AstraZeneca
Pfizer
Johnson & Johnson
Boehringer Ingelheim
Bristol-Myers Squibb
Daiichi Sankyo
Genentech (Roche)
Lilly
Otsuka
Bayer
The Medicines Company
Aspen
By Type:
Platelet aggregation inhibitors (PAI)
Low-molecular-weight Heparin (LMWH)
Direct thrombin inhibitor (DTI)
Direct factor Xa inhibitors (DFXa)
Vitamin K antagonists (VKA)
Others
By End-User:
VTE
ACS/MI
AF
Other
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Anticoagulants Market
-
1.3 Market Segment by Type
-
1.3.1 USA Anticoagulants Market Size and Growth Rate of Platelet aggregation inhibitors (PAI) from 2016 to 2027
-
1.3.2 USA Anticoagulants Market Size and Growth Rate of Low-molecular-weight Heparin (LMWH) from 2016 to 2027
-
1.3.3 USA Anticoagulants Market Size and Growth Rate of Direct thrombin inhibitor (DTI) from 2016 to 2027
-
1.3.4 USA Anticoagulants Market Size and Growth Rate of Direct factor Xa inhibitors (DFXa) from 2016 to 2027
-
1.3.5 USA Anticoagulants Market Size and Growth Rate of Vitamin K antagonists (VKA) from 2016 to 2027
-
1.3.6 USA Anticoagulants Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Anticoagulants Market Size and Growth Rate of VTE from 2016 to 2027
-
1.4.2 USA Anticoagulants Market Size and Growth Rate of ACS/MI from 2016 to 2027
-
1.4.3 USA Anticoagulants Market Size and Growth Rate of AF from 2016 to 2027
-
1.4.4 USA Anticoagulants Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Anticoagulants Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Anticoagulants Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Anticoagulants Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Anticoagulants Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Anticoagulants Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Anticoagulants by Major Types
-
3.4.1 Market Size and Growth Rate of Platelet aggregation inhibitors (PAI)
-
3.4.2 Market Size and Growth Rate of Low-molecular-weight Heparin (LMWH)
-
3.4.3 Market Size and Growth Rate of Direct thrombin inhibitor (DTI)
-
3.4.4 Market Size and Growth Rate of Direct factor Xa inhibitors (DFXa)
-
3.4.5 Market Size and Growth Rate of Vitamin K antagonists (VKA)
-
3.4.6 Market Size and Growth Rate of Others
4 Segmentation of Anticoagulants Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Anticoagulants by Major End-Users
-
4.4.1 Market Size and Growth Rate of Anticoagulants in VTE
-
4.4.2 Market Size and Growth Rate of Anticoagulants in ACS/MI
-
4.4.3 Market Size and Growth Rate of Anticoagulants in AF
-
4.4.4 Market Size and Growth Rate of Anticoagulants in Other
5 Market Analysis by Regions
-
5.1 USA Anticoagulants Production Analysis by Regions
-
5.2 USA Anticoagulants Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Anticoagulants Landscape Analysis
-
6.1 West USA Anticoagulants Landscape Analysis by Major Types
-
6.2 West USA Anticoagulants Landscape Analysis by Major End-Users
7 South USA Anticoagulants Landscape Analysis
-
7.1 South USA Anticoagulants Landscape Analysis by Major Types
-
7.2 South USA Anticoagulants Landscape Analysis by Major End-Users
8 Middle West USA Anticoagulants Landscape Analysis
-
8.1 Middle West USA Anticoagulants Landscape Analysis by Major Types
-
8.2 Middle West USA Anticoagulants Landscape Analysis by Major End-Users
9 Northeast USA Anticoagulants Landscape Analysis
-
9.1 Northeast USA Anticoagulants Landscape Analysis by Major Types
-
9.2 Northeast USA Anticoagulants Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Sanofi
-
10.1.1 Sanofi Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 AstraZeneca
-
10.2.1 AstraZeneca Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Pfizer
-
10.3.1 Pfizer Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Johnson & Johnson
-
10.4.1 Johnson & Johnson Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Boehringer Ingelheim
-
10.5.1 Boehringer Ingelheim Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Bristol-Myers Squibb
-
10.6.1 Bristol-Myers Squibb Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Daiichi Sankyo
-
10.7.1 Daiichi Sankyo Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Genentech (Roche)
-
10.8.1 Genentech (Roche) Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Lilly
-
10.9.1 Lilly Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Otsuka
-
10.10.1 Otsuka Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Bayer
-
10.11.1 Bayer Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 The Medicines Company
-
10.12.1 The Medicines Company Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 Aspen
-
10.13.1 Aspen Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Anticoagulants Market Size and Growth Rate of Platelet aggregation inhibitors (PAI) from 2016 to 2027
-
Figure USA Anticoagulants Market Size and Growth Rate of Low-molecular-weight Heparin (LMWH) from 2016 to 2027
-
Figure USA Anticoagulants Market Size and Growth Rate of Direct thrombin inhibitor (DTI) from 2016 to 2027
-
Figure USA Anticoagulants Market Size and Growth Rate of Direct factor Xa inhibitors (DFXa) from 2016 to 2027
-
Figure USA Anticoagulants Market Size and Growth Rate of Vitamin K antagonists (VKA) from 2016 to 2027
-
Figure USA Anticoagulants Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Anticoagulants Market Size and Growth Rate of VTE from 2016 to 2027
-
Figure USA Anticoagulants Market Size and Growth Rate of ACS/MI from 2016 to 2027
-
Figure USA Anticoagulants Market Size and Growth Rate of AF from 2016 to 2027
-
Figure USA Anticoagulants Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Anticoagulants Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Anticoagulants Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Anticoagulants Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Anticoagulants Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Anticoagulants Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Anticoagulants
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Anticoagulants by Different Types from 2016 to 2027
-
Table Consumption Share of Anticoagulants by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Platelet aggregation inhibitors (PAI)
-
Figure Market Size and Growth Rate of Low-molecular-weight Heparin (LMWH)
-
Figure Market Size and Growth Rate of Direct thrombin inhibitor (DTI)
-
Figure Market Size and Growth Rate of Direct factor Xa inhibitors (DFXa)
-
Figure Market Size and Growth Rate of Vitamin K antagonists (VKA)
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Anticoagulants by Different End-Users from 2016 to 2027
-
Table Consumption Share of Anticoagulants by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of VTE
-
Figure Market Size and Growth Rate of ACS/MI
-
Figure Market Size and Growth Rate of AF
-
Figure Market Size and Growth Rate of Other
-
Table USA Anticoagulants Production by Regions
-
Table USA Anticoagulants Production Share by Regions
-
Figure USA Anticoagulants Production Share by Regions in 2016
-
Figure USA Anticoagulants Production Share by Regions in 2021
-
Figure USA Anticoagulants Production Share by Regions in 2027
-
Table USA Anticoagulants Consumption by Regions
-
Table USA Anticoagulants Consumption Share by Regions
-
Figure USA Anticoagulants Consumption Share by Regions in 2016
-
Figure USA Anticoagulants Consumption Share by Regions in 2021
-
Figure USA Anticoagulants Consumption Share by Regions in 2027
-
Table West USA Anticoagulants Consumption by Types from 2016 to 2027
-
Table West USA Anticoagulants Consumption Share by Types from 2016 to 2027
-
Figure West USA Anticoagulants Consumption Share by Types in 2016
-
Figure West USA Anticoagulants Consumption Share by Types in 2021
-
Figure West USA Anticoagulants Consumption Share by Types in 2027
-
Table West USA Anticoagulants Consumption by End-Users from 2016 to 2027
-
Table West USA Anticoagulants Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Anticoagulants Consumption Share by End-Users in 2016
-
Figure West USA Anticoagulants Consumption Share by End-Users in 2021
-
Figure West USA Anticoagulants Consumption Share by End-Users in 2027
-
Table South USA Anticoagulants Consumption by Types from 2016 to 2027
-
Table South USA Anticoagulants Consumption Share by Types from 2016 to 2027
-
Figure South USA Anticoagulants Consumption Share by Types in 2016
-
Figure South USA Anticoagulants Consumption Share by Types in 2021
-
Figure South USA Anticoagulants Consumption Share by Types in 2027
-
Table South USA Anticoagulants Consumption by End-Users from 2016 to 2027
-
Table South USA Anticoagulants Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Anticoagulants Consumption Share by End-Users in 2016
-
Figure South USA Anticoagulants Consumption Share by End-Users in 2021
-
Figure South USA Anticoagulants Consumption Share by End-Users in 2027
-
Table Middle West USA Anticoagulants Consumption by Types from 2016 to 2027
-
Table Middle West USA Anticoagulants Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Anticoagulants Consumption Share by Types in 2016
-
Figure Middle West USA Anticoagulants Consumption Share by Types in 2021
-
Figure Middle West USA Anticoagulants Consumption Share by Types in 2027
-
Table Middle West USA Anticoagulants Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Anticoagulants Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Anticoagulants Consumption Share by End-Users in 2016
-
Figure Middle West USA Anticoagulants Consumption Share by End-Users in 2021
-
Figure Middle West USA Anticoagulants Consumption Share by End-Users in 2027
-
Table Northeast USA Anticoagulants Consumption by Types from 2016 to 2027
-
Table Northeast USA Anticoagulants Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Anticoagulants Consumption Share by Types in 2016
-
Figure Northeast USA Anticoagulants Consumption Share by Types in 2021
-
Figure Northeast USA Anticoagulants Consumption Share by Types in 2027
-
Table Northeast USA Anticoagulants Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Anticoagulants Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Anticoagulants Consumption Share by End-Users in 2016
-
Figure Northeast USA Anticoagulants Consumption Share by End-Users in 2021
-
Figure Northeast USA Anticoagulants Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of Boehringer Ingelheim
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim
-
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim
-
Figure Revenue and Market Share Analysis of Boehringer Ingelheim
-
Table Product and Service Introduction of Boehringer Ingelheim
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of Daiichi Sankyo
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo
-
Figure Sales and Growth Rate Analysis of Daiichi Sankyo
-
Figure Revenue and Market Share Analysis of Daiichi Sankyo
-
Table Product and Service Introduction of Daiichi Sankyo
-
Table Company Profile and Development Status of Genentech (Roche)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech (Roche)
-
Figure Sales and Growth Rate Analysis of Genentech (Roche)
-
Figure Revenue and Market Share Analysis of Genentech (Roche)
-
Table Product and Service Introduction of Genentech (Roche)
-
Table Company Profile and Development Status of Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lilly
-
Figure Sales and Growth Rate Analysis of Lilly
-
Figure Revenue and Market Share Analysis of Lilly
-
Table Product and Service Introduction of Lilly
-
Table Company Profile and Development Status of Otsuka
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Otsuka
-
Figure Sales and Growth Rate Analysis of Otsuka
-
Figure Revenue and Market Share Analysis of Otsuka
-
Table Product and Service Introduction of Otsuka
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of The Medicines Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of The Medicines Company
-
Figure Sales and Growth Rate Analysis of The Medicines Company
-
Figure Revenue and Market Share Analysis of The Medicines Company
-
Table Product and Service Introduction of The Medicines Company
-
Table Company Profile and Development Status of Aspen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aspen
-
Figure Sales and Growth Rate Analysis of Aspen
-
Figure Revenue and Market Share Analysis of Aspen
-
Table Product and Service Introduction of Aspen
-
